IntelGenx Technologies Corp. (IntelGenx) is a drug delivery company focusing on the development of orally administered drug delivery products-based on its oral drug delivery technologies. The Company is a provider of product development services for the pharmaceutical industry. It develops product-based on three delivery platform technologies: VersaFilm, an Oral Film technology; VersaTab, a Multilayer Tablet technology, and AdVersa, a Mucoadhesive Tablet technology. The Oral Film technology consists of a thin (25-35 micron) polymeric film consisting of United States Pharmacopeia (USP) components. The VersaFilm technology is intended for indications requiring rapid onset of action, such as migraine, opioid dependence, motion sickness, erectile dysfunction, and nausea. Its product portfolio includes INT0001/2004, INT0004/2006, INT0007/2006, INT0008/2007, INT0010/2006, INT0024/2010, INT0027/2011, INT0030/2011, INT0036/2013, INT0037/2013, INT0039/2013 and INT0040/2014.